As President of Avita, Kevin uses his deep experience in the specialty pharmacy industry to help Avita clients generate savings through the 340B program, grow their patient base, and extend care for more people in their communities. As a trained pharmacist, Kevin seeks to improve the patient journey by implementing clinical programs and new technologies to better engage patients and providers and improve outcomes.
Before joining Avita in 2019, Kevin was the President of Pharmaceutical Strategies Group where he led two divisions – professional services and technology-enabled services. Kevin led a team of highly skilled pharmacy industry consultants who worked with health plans and fortune-500 companies to optimize their pharmacy benefit programs for their members and employees. In the technology-enabled services division, Kevin’s team built proprietary software and provided services that maximized the use and compliance of the 340B drug purchasing programs for some of the largest health systems in the country.
“I lead my teams using a philosophy of servant leadership to collaborate and create solutions to better both our patients and our partners.”
Kevin received his Doctor of Pharmacy degree from University of the Pacific and is one of the early leaders in the foundation of the specialty pharmacy industry which elevated the practice of pharmacy by dedicating clinical teams to provide pharmaceutical care to patients taking oral and injectable therapies for complex medical conditions. Over the years, Kevin has served on several boards of directors helping to develop and direct the strategic growth of those industry trade groups and for-profit organizations.